Search Within

Sujata Patil

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (70)
  2. Journal Article (55)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Biostatistics Service (127)
  2. Department of Medicine (127)
  3. Epidemiology and Biostatistics (127)
  4. Population Sciences Research Program (127)
  5. Solid Tumor Oncology Division (126)
  6. Survivorship Research (106)

More Groups

People
  1. Clifford Hudis (44)
  2. Shari Goldfarb (34)
  3. Mark Robson (32)
  4. Chau Dang (30)
  5. Larry Norton (29)
  6. Shanu Modi (25)

More People

Years
  1. 2023 (2)
  2. 2022 (6)
  3. 2021 (10)
  4. 2020 (17)
  5. 2019 (14)
  6. 2018 (10)

More Years

Publications
  1. Journal of Clinical Oncology (44)
  2. Cancer Research (18)
  3. Breast Cancer Research and Treatment (9)
  4. Cancer (7)
  5. The Oncologist (5)
  6. Annals of Surgical Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (45)
  2. American Association for Cancer Research (22)
  3. Springer (13)
  4. Elsevier Inc. (10)
  5. Wiley Blackwell (8)
  6. Oxford University Press (5)

More Publishers

Results (127)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparative patient-centered outcomes (health state and adverse sexual symptoms) between adjuvant brachytherapy versus no adjuvant brachytherapy in early stage endometrial cancer
    Journal Article

    Damast, S.; Alektiar, K.; Eaton, A.; Gerber, N. K.; Goldfarb, S.; Patil, S.; Jia, R.; Leitao, M.; Carter, J.; Basch, E.
    Annals of Surgical Oncology (2014)

    Fulltext@MSK | Save
  • A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with Metastatic breast cancer
    Journal Article

    Jhaveri, K.; Chandarlapaty, S.; Lake, D.; Gilewski, T.; Robson, M.; Goldfarb, S.; Drullinsky, P.; Sugarman, S.; Wasserheit Leiblich, C.; Fasano, J.; more...
    Clinical Breast Cancer (2014)

    Fulltext@MSK | Save
  • Predictors of adequate financial resources 5 years after breast cancer diagnosis in low-income women
    Meeting Abstract

    Patil, S.; Blinder, V. S.; Gany, F.; Maly, R. C.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
    Meeting Abstract

    Morris, P. G.; Iyengar, N. M.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R. J.; Steingart, R.; Oeffinger, K. C.; Lin, N.; Moy, B.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Use of intravaginal 17-ß estradiol to improve sexual function and menopausal symptoms in postmenopausal women with breast cancer on aromatase inhibitors
    Meeting Abstract

    Goldfarb, S. B.; Dickler, M. N.; Dnistrian, A. M.; Patil, S.; Dunn, L.; Chang, K.; Berkowitz, A. P.; Tucker, N.; Carter, J.; Barakat, R. R.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Five-year trajectories of financial recovery in low-income breast cancer survivors
    Meeting Abstract

    Blinder, V. S.; Patil, S.; Gany, F.; Maly, R. C.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data
    Meeting Abstract

    Iyengar, N. M.; Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Morris, P. G.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R. J.; Steingart, R.; Oeffinger, K. C.; Lin, N. U.; Moy, B.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer
    Journal Article

    Morris, P. G.; Iyengar, N. M.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R.; Steingart, R.; Oeffinger, K. C.; Lin, N.; Moy, B.; more...
    Cancer (2013)

    Fulltext@MSK | Save